International Assets Investment Management’s Pacer BioThreat Strategy ETF VIRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-18,355
Closed -$667K 2717
2024
Q2
$667K Sell
18,355
-310
-2% -$11.1K 0.06% 296
2024
Q1
$671K Sell
18,665
-324
-2% -$11.1K 0.07% 291
2023
Q4
$614K Buy
+18,989
New +$572K 0.08% 283
2020
Q4
Sell
-108,640
Closed -$3.05M 2148
2020
Q3
$3.05M Buy
+108,640
New +$2.93M 0.76% 25

Other funds holding VIRS

International Assets Investment Management's VIRS Position: Q3 2024 in Review

International Assets Investment Management sold out of Pacer BioThreat Strategy ETF (VIRS) in Q3 2024, closing a stake of 18,355 shares — an estimated $667K sold.

International Assets Investment Management first reported a position in VIRS in Q3 2020 and held it in 4 quarters. The position peaked at $3.05M in Q3 2020. 4 funds tracked by Wall St. Rank hold VIRS as of Q3 2024.

  • International Assets Investment Management reported no remaining Pacer BioThreat Strategy ETF position as of Q3 2024 after selling out during the quarter.
  • International Assets Investment Management sold 18,355 Pacer BioThreat Strategy ETF shares in Q3 2024, an estimated $667K.
  • International Assets Investment Management first reported a position in Pacer BioThreat Strategy ETF in Q3 2020 and held it in 4 quarters.
  • International Assets Investment Management's Pacer BioThreat Strategy ETF position peaked at $3.05M in Q3 2020.
  • 4 funds tracked by Wall St. Rank held Pacer BioThreat Strategy ETF as of Q3 2024.

Based on International Assets Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.